Literature DB >> 18326969

The Food and Drug Administration and over-the-counter statins: an opportunity lost?

Thomas G Pickering1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326969      PMCID: PMC8109854          DOI: 10.1111/j.1751-7176.2008.08047.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

Review 1.  Risks of statin use during pregnancy: a systematic review.

Authors:  Aleksey Kazmin; Facundo Garcia-Bournissen; Gideon Koren
Journal:  J Obstet Gynaecol Can       Date:  2007-11

2.  Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Authors:  Jeffrey S Berger; Maria C Roncaglioni; Fausto Avanzini; Ierta Pangrazzi; Gianni Tognoni; David L Brown
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

3.  Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.

Authors:  Donna K Arnett; David R Jacobs; Russell V Luepker; Henry Blackburn; Christopher Armstrong; Steven A Claas
Journal:  Circulation       Date:  2005-12-12       Impact factor: 29.690

4.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

5.  The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database.

Authors:  Kristian B Filion; J A Chris Delaney; James M Brophy; Pierre Ernst; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-01       Impact factor: 2.890

6.  The National Lipid Association surveys of consumers, physicians, and pharmacists regarding an over-the-counter statin in the United States: is this a good idea?

Authors:  James M McKenney; W Virgil Brown; Jerome D Cohen; Edward Cahill
Journal:  Am J Cardiol       Date:  2004-11-04       Impact factor: 2.778

Review 7.  Statin safety: a systematic review.

Authors:  Malcolm Law; Alicja R Rudnicka
Journal:  Am J Cardiol       Date:  2006-02-03       Impact factor: 2.778

8.  Potential impact on cardiovascular public health of over-the-counter statin availability.

Authors:  Eric P Brass; Shannon E Allen; Jeffrey M Melin
Journal:  Am J Cardiol       Date:  2006-01-30       Impact factor: 2.778

9.  A Consumer Use Study of Over-The-Counter lovastatin (CUSTOM).

Authors:  Jeffrey M Melin; William E Struble; Robert W Tipping; James M Reynolds; Theodore C Vassil; Stephanie J Levy; Theresa M Petrohoy; Paulette Midgette; Edwin L Hemwall; Jeffrey G Levine; John D Irvin
Journal:  Am J Cardiol       Date:  2004-11-15       Impact factor: 2.778

10.  Risk of congenital anomalies in pregnant users of statin drugs.

Authors:  Benjamin Ofori; Evelyne Rey; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.